RPG Life Sciences Limited (RPGLIFE) — Corporate Action | 29 April 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

RPG Life Sciences announced its audited financial results for the quarter and year ended March 31, 2026, along with a dividend recommendation of Rs.24 per share (300% payout on a Rs.8 face value) subject to shareholder approval at the upcoming AGM, and the appointment of Dr. Pratit Samdani as an additional non-executive independent director for five years effective April 29, 2026.

📄 View Original Announcement (PDF)

About RPG Life Sciences Limited (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,509.45 Cr P/E: 37.7 ROE: 19.8% ROCE: 25.8% Div Yield: 0.88%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

📊 More RPGLIFE filings

See all RPGLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day